“Many pharma units here have suffered extensive damage due to Cyclone Hudhud. While the asbestos ceilings were torn off and conveyor belts, boilers and other manufacturing equipment damaged, the raw material was completely washed away. According to preliminary estimates, the loss could be about Rs 200 crore,” a pharmaceutical unit official told Business Standard.
There are over 150 pharmaceutical units in Visakhapatnam, Srikakulam and Vizianagaram districts, providing direct and indirect employment to over 15,000. Most of these were set up as part of Hyderabad-based pharma companies’ expansion.
These firms looked at Vizag and neighbouring districts as an alternative to Hyderabad as the Pollution Control Board had been denying permission to expand existing units in Hyderabad since the last eight years owing to the increasing pollution by the pharma industry.
At the Paravada Pharma City, set up on the outskirts on Visakhapatnam seven years ago, expansion activities had been severely hampered by Hudhud.
“Close to 110 companies have received approvals to set up manufacturing units at the Pharma City. While production at 40 units has already begun, 20 units are in various stages of development. All these activities have come to a standstill now,” a government official said.
According to him, the units at Pharma City had incurred a loss of around Rs 50 crore. With the power supply to the units is expected only after 10 days, this loss could go up further, he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)